Clinical Trial Update: Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children [Phase 2]

View source ↗

Summary

Phase II trial evaluating anti-CD19 CAR-T cell therapy for pediatric acute lymphoblastic leukemia, including relapsed and refractory cases; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Anti-CD19 CAR T cells (CD19-directed CAR T cells)

Snippet

Sponsor: Beijing Boren Hospital | Conditions: Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphoblastic Leukemia, in Relapse | Phase 2 | Status: COMPLETED